Dusseldorf - Delayed Quote EUR
Protalix BioTherapeutics Inc (PBDA.DU)
2.6200
+0.1800
+(7.38%)
At close: April 30 at 4:00:08 PM GMT+2
Loading Chart for PBDA.DU
- Previous Close
2.4400 - Open
2.5400 - Bid 2.6600 x --
- Ask 2.7600 x --
- Day's Range
2.5400 - 2.6200 - 52 Week Range
0.6396 - 2.6800 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 8, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: PBDA.DU
View MorePerformance Overview: PBDA.DU
Trailing total returns as of 5/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
PBDA.DU
51.27%
S&P 500 (^GSPC)
4.40%
1-Year Return
PBDA.DU
145.09%
S&P 500 (^GSPC)
12.05%
3-Year Return
PBDA.DU
142.48%
S&P 500 (^GSPC)
36.08%
5-Year Return
PBDA.DU
15.93%
S&P 500 (^GSPC)
98.64%
Compare To: PBDA.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PBDA.DU
View MoreValuation Measures
As of 4/30/2025
Market Cap
210.36M
Enterprise Value
184.63M
Trailing P/E
74.59
Forward P/E
6.78
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.53
Price/Book (mrq)
5.39
Enterprise Value/Revenue
3.94
Enterprise Value/EBITDA
32.25
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--